Veritas has agreed to acquire a majority stake in Global Healthcare Exchange (GHX), a supply chain software platform that connects healthcare providers with suppliers. Veritas will partner with existing GHX shareholders Temasek and Warburg Pincus to support the company’s next phase of growth.
GHX delivers cloud-based supply chain solutions to healthcare systems and medical-surgical suppliers, combining AI-driven automation with intelligent decision support.
“This investment enables us to move faster and think bigger about building a more resilient, AI-enabled supply chain,” said Tina Vatanka Murphy, president and CEO of GHX, in a statement. “The partnership will allow us to accelerate product innovation, pursue both organic and inorganic growth, and further advance our AI-powered supply chain strategy.”
By digitizing and automating complex healthcare supply chain processes, GHX aims to reduce inefficiencies and help organizations better leverage their data. Increased investment in AI is expected to enhance workflow simplification, actionable insights, automated decision-making, and ultimately, care delivery.
The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions, including regulatory approvals. Veritas is a technology investor with over $54 billion of assets under management with a focus on companies operating at the intersection of technology and government.
